The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
出版年份 2014 全文链接
标题
The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 1, Pages 230-255
出版商
MDPI AG
发表日期
2014-12-25
DOI
10.3390/ijms16010230
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
- (2015) Paul C. McDonald et al. Oncotarget
- Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
- (2014) Walhan Alshaer et al. BIOCONJUGATE CHEMISTRY
- Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies
- (2014) Brandon S Brown et al. CANCER BIOLOGY & THERAPY
- Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells
- (2014) Lāsma Ivanova et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells
- (2014) Joy Wolfram et al. JOURNAL OF MICROENCAPSULATION
- Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
- (2014) Henning Hanken et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients
- (2014) Pawel Sadlecki et al. Biomed Research International
- A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes
- (2013) Jared F. Stefanick et al. ACS Nano
- Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity
- (2013) Elisa Dalla Pozza et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells
- (2013) Christian Celia et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Effect of Liposomes on the Absorption of Water-soluble Active Pharmaceutical Ingredients via Oral Administration
- (2013) Zhijun Yang et al. CURRENT PHARMACEUTICAL DESIGN
- Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel
- (2013) Anandhkumar Raju et al. Expert Opinion on Drug Delivery
- Liposomes in drug delivery: a patent review (2007 – present)
- (2013) José L Arias EXPERT OPINION ON THERAPEUTIC PATENTS
- Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome
- (2013) Steven A Schneider et al. MODERN PATHOLOGY
- Ligand-targeted liposome design: challenges and fundamental considerations
- (2013) Gavin T. Noble et al. TRENDS IN BIOTECHNOLOGY
- Tumor Endothelial Cells
- (2013) A. C. Dudley Cold Spring Harbor Perspectives in Medicine
- Surface Engineering of Liposomes for Stealth Behavior
- (2013) Okhil Nag et al. Pharmaceutics
- Challenges in Development of Targeted Liposomal Therapeutics
- (2012) Rupa R. Sawant et al. AAPS Journal
- Immunoconjugates and long circulating systems: Origins, current state of the art and future directions
- (2012) Alexander Koshkaryev et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model
- (2012) Donatella Paolino et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Binding of the Phage Display Derived Peptide CaIX-P1 on Human Colorectal Carcinoma Cells Correlates with the Expression of Carbonic Anhydrase IX
- (2012) Vasileios Askoxylakis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer
- (2012) Donatella Paolino et al. Nanomedicine
- Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
- (2012) Evripidis Lanitis et al. PLoS One
- HER2 expression in renal cell carcinoma is rare and negatively correlated with that in normal renal tissue
- (2012) HUILI WANG et al. Oncology Letters
- Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems
- (2012) Eisaku Kondo et al. Nature Communications
- Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis
- (2011) Su-jong Yu et al. ACTA PHARMACOLOGICA SINICA
- Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
- (2011) Linn Woelber et al. BMC CANCER
- RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studies
- (2011) Wei Li et al. EUROPEAN JOURNAL OF RADIOLOGY
- Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
- (2011) Cheng-Wei Chen et al. International Journal of Nanomedicine
- Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
- (2011) H.-J. Shin et al. JOURNAL OF CELL SCIENCE
- Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
- (2011) H. M. Petrul et al. MOLECULAR CANCER THERAPEUTICS
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology
- (2011) Vasileios Askoxylakis et al. PLoS One
- Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer
- (2011) Matthias Choschzick et al. VIRCHOWS ARCHIV
- Carbonic Anhydrase IX Expression in Renal Neoplasms
- (2010) Elizabeth M. Genega et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis
- (2010) Kristiina Nordfors et al. BMC CANCER
- High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
- (2010) M İlie et al. BRITISH JOURNAL OF CANCER
- Efficacy, Biodistribution, and Pharmacokinetics of CD22-Targeted Pegylated Liposomal Doxorubicin in a B-cell Non-Hodgkin's Lymphoma Xenograft Mouse Model
- (2010) J. M. Tuscano et al. CLINICAL CANCER RESEARCH
- Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
- (2010) M. Zatovicova et al. CURRENT PHARMACEUTICAL DESIGN
- Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
- (2010) Donatella Paolino et al. JOURNAL OF CONTROLLED RELEASE
- Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor
- (2010) Arehalli S. Manjappa et al. JOURNAL OF CONTROLLED RELEASE
- Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer Cells
- (2010) F. Cianchi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation
- (2010) P Swietach et al. ONCOGENE
- A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
- (2010) M. Siebels et al. WORLD JOURNAL OF UROLOGY
- Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
- (2009) P. J. Barrett-Lee et al. ANNALS OF ONCOLOGY
- Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
- (2009) Giuseppina De Simone et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors
- (2009) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development
- (2009) Shu-Yuan Liao et al. BMC DEVELOPMENTAL BIOLOGY
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
- (2009) E Y Tan et al. BRITISH JOURNAL OF CANCER
- Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer
- (2009) E Korkeila et al. BRITISH JOURNAL OF CANCER
- Carbonic anhydrase IX in bladder cancer
- (2009) Tobias Klatte et al. CANCER
- In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
- (2009) Donato Cosco et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Expression and Mutation Analysis of Her2 in Head and Neck Squamous Cell Carcinoma
- (2009) Mahmoud AL Sheikh Ali et al. CANCER INVESTIGATION
- A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy
- (2009) Yuki Murase et al. CANCER LETTERS
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths
- (2009) Pawel Swietach et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Generating specificity and diversity in the transcriptional response to hypoxia
- (2009) Urban Lendahl et al. NATURE REVIEWS GENETICS
- Carbonic anhydrase IX expression in prostate cancer
- (2009) L G Smyth et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
- (2008) J. Chiche et al. CANCER RESEARCH
- Cancer-Associated Carbonic Anhydrases and Their Inhibition
- (2008) J. Pastorek et al. CURRENT PHARMACEUTICAL DESIGN
- Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma
- (2008) Sung-Weon Choi et al. HUMAN PATHOLOGY
- Drug targeting and tumor heterogeneity
- (2008) You Han Bae JOURNAL OF CONTROLLED RELEASE
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
- Membrane lipids: where they are and how they behave
- (2008) Gerrit van Meer et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started